iBio, Inc.
IBIO
$1.04
-$0.03-2.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -50.00% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -50.00% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -50.00% | -- | |||
| SG&A Expenses | 15.04% | -26.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.10% | 10.64% | |||
| Operating Income | -14.49% | -6.54% | |||
| Income Before Tax | -10.79% | -6.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.79% | -6.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.79% | -6.21% | |||
| EBIT | -14.49% | -6.54% | |||
| EBITDA | -15.19% | -6.43% | |||
| EPS Basic | 18.92% | 27.21% | |||
| Normalized Basic EPS | 18.91% | 27.23% | |||
| EPS Diluted | 18.92% | 27.21% | |||
| Normalized Diluted EPS | 18.91% | 27.23% | |||
| Average Basic Shares Outstanding | 36.66% | 45.91% | |||
| Average Diluted Shares Outstanding | 36.66% | 45.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||